AWA
AMRX icon

Arkadios Wealth Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Arkadios Wealth Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.71M Sell
329,652
-5,446
-2% -$74.6K 0.09% 238
2026
Q1 		$4.17M Buy
+335,098
New +$4.5M 0.07% 298

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Arkadios Wealth Advisors's AMRX Position: Q2 2026 in Review

Arkadios Wealth Advisors reduced its Amneal Pharmaceuticals (AMRX) stake by 1.6% in Q2 2026, selling an estimated $74.6K and leaving 329,652 shares worth $5.71M. The position accounts for 0.09% of the portfolio, ranked #238.

Arkadios Wealth Advisors first reported a position in AMRX in Q1 2026 and has held it in 2 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Arkadios Wealth Advisors held 329,652 shares of Amneal Pharmaceuticals worth $5.71M as of Q2 2026.
  • Arkadios Wealth Advisors sold 5,446 Amneal Pharmaceuticals shares in Q2 2026, an estimated $74.6K.
  • Amneal Pharmaceuticals made up 0.09% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #238 holding.
  • Arkadios Wealth Advisors first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.